Deal, C,
Steelman, J,
Vlachopapadopoulou, E,
Stawerska, R,
Silverman, LA;,
Phillip, M,
Kim, HS,
Ko, CW,
Malievskiy, O,
Cara, JF,
Roland, CL,
Taylor, CT,
Valluri, SR,
Wajnrajch, MP,
Pastrak, A,
Miller, BS (2022) (0.24 mg/kg/week) for 12 months. A
total of 228 prepubertal children
(boys aged 3-11 years, girls
Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) , respectively. In
total, 35 serious adverse events (SAEs) were reported in 27 patients (19.7%) of the SAF
Han, Dayong,
Teng, Lei,
Wang, Xiaoxiong,
Zhen, Yunbo,
Chen, Xiaofeng,
Yang, Mingchun,
Gao, Ming,
Yang, Guang,
Han, Mingyang,
Wang, Ligang,
Xu, Jiajun,
Li, Yue,
Shumadalova, Alina,
Zhao, Shiguang (2022) into the tumor cavity for 5 consecutive days every 3 months for a
total of eight cycles unless tumor progression
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) : We identified a
total of 63 eligible trials recruiting 9168 participants, most of which provided data